Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PeptidesRx vs Rixa Health

PeptidesRx
Graded #240

Higher grade

vs+3.9000000000000057
Rixa Health
Graded #320

Lower grade

The verdict

PeptidesRx takes it — 64.4/100 to 60.5/100.

PeptidesRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PeptidesRx is a Fort Worth, TX-based licensed telehealth platform offering physician-supervised compounded semaglutide, tirzepatide, and a broader prescription peptide menu.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePeptidesRx +17
62
45
Dose & formulationPeptidesRx +3
54
51
Clinical oversightEven
85
85
Labs & monitoringRixa Health +8
55
63
FulfillmentRixa Health +8
70
78
Contract termsPeptidesRx +14
55
41
PeptidesRx · left barRixa Health · right bar

The numbers

MetricPeptidesRxRixa Health
WeighScore64.4/10060.5/100
GradeCC
Scorecard rank#240#320
Semaglutide$169/mo (0.25 mg dose, compounded)Not disclosed
Tirzepatide$309/mo (2.5 mg dose, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
PeptidesRx

Graded #240 · C

Strengths

  • Compliance-focused positioning vs gray-market vendors
  • Board-certified medical director
  • Transparent pricing with no surprise fees
  • Real prescriptions, not research-chemical channel

Where it loses points

  • Smaller scale than Henry Meds or Hims
  • Wide peptide menu may distract from GLP-1 focus
Rixa Health

Graded #320 · C

Strengths

  • Functional-medicine, root-cause clinical approach
  • Compounded and oral semaglutide plus tirzepatide offered
  • Board-certified DO and FNP providers with years of experience
  • Medication bundled with visits into a single price
  • No charge until after approval

Where it loses points

  • No public monthly pricing; quoted only during consultation
  • Relies on compounded GLP-1, which is not FDA-approved as a finished drug
  • A handful of states still listed as coming soon
  • Branded GLP-1 medications are not the primary offering
  • Requires ongoing monthly follow-up commitment

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard